Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AVROBIO, Inc. (AVRO)
|
Add to portfolio |
|
|
|
| Price: |
$4.04
| | Metrics |
| OS: |
44.5
|
M
| |
-4
|
% ROE
|
| Market cap: |
$180
|
M
| |
2105
|
% ROIC
|
|
Net cash:
|
$125
|
M
| |
$2.80
|
per share
|
|
EV:
|
$55.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$79.5
|
M
| |
0.7
|
x EV/EBITDA
|
|
EBIT
|
$78.2
|
M
| |
0.7
|
x EV/EBIT
|
| EPS |
($0.14)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.7 |
| Revenue growth | | | | | | -100.0% | |
| Cost of goods sold | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.6 |
| Gross profit | -3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 |
| Gross margin | | | | | | | -73.7% |
| Selling, general and administrative | 105.4 | 118.8 | | | | 18.4 | |
| Research and development | | | 87.2 | 55.0 | 35.1 | | |
| General and administrative | | | 33.0 | 20.8 | 11.1 | | 2.0 |
| EBIT | -106.3 | -119.4 | -120.2 | -75.8 | -46.2 | -18.9 | -4.6 |
| EBIT margin | | | | | | | -173.7% |
| Pre-tax income | -105.9 | -119.1 | -119.7 | -73.0 | -46.4 | -18.6 | -4.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -105.9 | -119.1 | -119.7 | -73.0 | -46.4 | -18.6 | -4.7 |
| Net margin | | | | | | | -175.1% |
| |
| Diluted EPS | ($2.42) | ($2.78) | ($3.31) | ($2.66) | ($3.45) | ($8.34) | ($2.29) |
| Shares outstanding (diluted) | 43.7 | 42.9 | 36.2 | 27.4 | 13.4 | 2.2 | 2.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|